Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A packaging system for SV40 vectors without viral coding sequences

B Fang1, P Koch, M Bouvet

  • 1Department of Thoracic and Cardiovascular SurgeryJ, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

Analytical Biochemistry
|January 31, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026
Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026
Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026
Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026
Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026
Same author

Phase II study of magrolimab combination therapies in patients with head and neck squamous-cell carcinoma.

ESMO open·2026
Same journal

Evaluation of a method for affinity measurement using solution equilibrium titration with magnetic beads.

Analytical biochemistry·2026
Same journal

Metabolomics approach using UHPLC/QE-MS for the Mechanism of He Xue Ming Mu Tablets on Non-Proliferative Diabetic Retinopathy.

Analytical biochemistry·2026
Same journal

UniRES-GO: Unified residue-level early fusion of sequence and predicted structure for protein function prediction.

Analytical biochemistry·2026
Same journal

IgG detection by enzyme-linked mass spectrometric assay versus color, fluorescent, ECL in buffer and serum.

Analytical biochemistry·2026
Same journal

A PCR-based assay for distinguishing between 293, 293T, and 293E cell lines.

Analytical biochemistry·2026
Same journal

Real-time spectrophotometric microplate assay for galactolipase activity using synthetic or natural galactolipids in mixed micelles.

Analytical biochemistry·2026
See all related articles

This study presents a novel system for packaging Simian virus 40 (SV40) vectors using recombinant adenoviruses. This method allows for efficient gene transfer vector production without viral coding sequences, yielding high-purity SV40 vectors.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Simian virus 40 (SV40) vectors have been utilized for gene expression in mammalian cells since the 1980s.
  • Recent applications include gene transfer in mice and human peripheral blood cells.
  • Existing methods for SV40 vector production face limitations.

Purpose of the Study:

  • To develop an efficient system for packaging SV40 vectors.
  • To achieve high yields of infectious SV40 vectors free of viral coding sequences.
  • To optimize the SV40 vector packaging process using recombinant adenoviruses.

Main Methods:

  • A system was developed utilizing recombinant adenoviruses to express SV40 capsids.
  • Plasmids containing the SV40 replication origin were packaged.

Related Experiment Videos

  • Helper adenoviruses were heat-inactivated post-packaging.
  • Main Results:

    • The system effectively packaged plasmids into SV40 capsids.
    • A high yield of infectious SV40 vector was achieved (approximately 3 x 10^5).
    • A high ratio of SV40 to adenoviral vector (approximately 1000:1) was obtained, with heat-inactivated helper adenoviruses showing no impact on SV40 vector infectivity.

    Conclusions:

    • A novel and efficient method for producing SV40 vectors has been established.
    • This system offers a high yield and purity of infectious SV40 vectors.
    • The developed packaging system is suitable for gene transfer applications.